Eam Investors, LLC Oric Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 12, 2023	BUY	$4.26 - $6.75 $542,097 - $858,957	127,253 Added 201.34%	190,455 $1.09 Million
Q1 2023 May 12, 2023	SELL	$4.26 - $6.75 $542,097 - $858,957	-127,253 Reduced 66.82%	63,202 $360,000
Q4 2022 Feb 14, 2023	BUY	$2.41 - $5.89 $458,996 - $1.12 Million	190,455 New	190,455 $1.12 Million

112

63.1M

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $406M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.